Press Release30 Apr 2024, 03:40 pm
Granules India Ltd. Announces US FDA Approval for Colchicine Capsules
AI Summary
Granules India Limited has announced that the US Food and Drug Administration (FDA) has approved its Abbreviated New Drug Application (ANDA) for Colchicine Capsules, 0.6 mg. This makes it the 64th ANDA approval for the company from the US FDA. The current annual market for Colchicine Capsules in the US is approximately $55 Million.
Key Highlights
- Granules India Ltd. receives US FDA approval for Colchicine Capsules, 0.6 mg
- ANDA approval marks Granules India's 64th approval from the US FDA
- Colchicine Capsules have an annual market size of approximately $55 Million in the US